The Board of Directors of the Company has deferred the agenda item for Consideration and approval of the Audited Standalone Financial Results of the Company for the Quarter and year ended March 31, 2025 till further notice.
The Board of Directors of the Company has deferred the agenda item for Consideration and approval of the Audited Standalone Financial Results of the Company for the Quarter and year ended March 31, 2025 till further notice.